Veeva SystemsBSP:V2EE34 97 Days Payable is 16.63 as of Apr. 2026, which is 4% above its 10-year median of 16.03. GuruFocus rates BSP:V2EE34 with a GF Score™ of 97/100 and a GF Value™ of R$48.56 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 607 Healthcare Providers & Services companies, Veeva Systems ranks worse than 86.49% on this metric.
The historical rank and industry rank for Veeva Systems's Days Payable or its related term are showing as below:
BSP:V2EE34'
s Days Payable Range Over the Past 10 Years
Min: 10.8 Med: 16.03 Max: 19.72
Current: 16.02
During the past 13 years, Veeva Systems's highest Days Payable was 19.72. The lowest was 10.80. And the median was 16.03.
BSP:V2EE34's Days Payable is ranked worse than 86.49% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs BSP:V2EE34: 16.02
Veeva Systems's Days Payable
declined
from Apr. 2025 (18.12) to Apr. 2026 (16.63).
It may suggest that Veeva Systemsaccelerated paying its suppliers.
Veeva Systems Days Payable Related Terms
Veeva Systems Days Payable Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:V2EE34 vs BTSG, TEM, HQY: Days Payable Comparison
For the Health Information Services subindustry, Veeva Systems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Days Payable distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Veeva Systems's Days Payable for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (BSP:V2EE34) has a Days Payable of 16.63 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Veeva Systems and its competitors. This is near median its historical median of 16.03. Over the past decade, Veeva Systems' Days Payable has ranged from 10.80 to 19.72. According to the industry distribution chart, Veeva Systems ranks #525 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 86.5%.
Is Veeva Systems' Days Payable too high?
Veeva Systems' current Days Payable of 16.63 is near median its 10-year median of 16.03. Over the past 10 years, this metric has ranged from a low of 10.80 to a high of 19.72. The Healthcare Providers & Services industry median Days Payable is 58.00. Veeva Systems' value of 16.63 is 71.3% below this industry median. Based on the distribution chart, Veeva Systems ranks #525 out of 607 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veeva Systems has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Days Payable compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #525 out of 607 companies for Days Payable. This places Veeva Systems in the lower half of its industry. The industry median Days Payable is 58.00. Veeva Systems' value of 16.63 is 71.3% below this benchmark. Historically, Veeva Systems' own Days Payable has ranged from 10.80 to 19.72 over the past decade. While the company's 10-year median is 16.03 vs. the industry median of 58.00, Veeva Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current Days Payable of 16.63 is 71.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Days Payable is 16.63, which is near median its own 10-year median of 16.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (BSP:V2EE34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$48.56, compared to a current price of R$32.73 — trading 32.6% below its estimated fair value. The current Days Payable is 16.63, which is near median its 10-year median of 16.03 and 71.3% below the Healthcare Providers & Services industry median of 58.00. Veeva Systems' overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Veeva Systems (BSP:V2EE34), the current Days Payable is 16.63 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (BSP:V2EE34) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of R$32.73 is trading 32.6% below its estimated GF Value™ of R$48.56.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for BSP:V2EE34:
Days Payable: 16.63 (near median its 10-year median of 16.03)
GF Value™: R$48.56 vs. price of R$32.73 (32.6% below fair value)
Industry Position: 71.3% below the Healthcare Providers & Services median (#525 of 607)
No single metric tells the full story. See the BSP:V2EE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
97GF Score
Get the complete analysis for BSP:V2EE34
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:V2EE34 has been successfully added to your 
